Andrew Huberman· PhD
In the earlier trials where they followed people out, it seemed to last for kind of in the years range for some people.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
In the earlier trials where they followed people out, it seemed to last for kind of in the years range for some people.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And long term. My understanding is some of those remission rates for trauma were years, which is different than what you're describing for psilocybin, where people might need ongoing dosing.